Five trends shaping the Asian biopharma market, diagnosing disease with smartphone camera and other interesting reads from the past week.

Noteworthy 📰

• NASH has dozens of treatments in the global pipeline but investors are treading lightly. Link

• Rush to protect lucrative antibody patents kicks into gear. Link

• FDA to fast-track certain gene therapies. Link

• Pfizer and drug supply chain debacle. Link

• Routine DNA screening moves into primary care. Link

Digital Health 💻

• London hospitals to replace doctors and nurses with AI for some tasks. Link

• This digital pill prototype uses bacteria to sense stomach bleeding. Link

Research 🔬

• “Living drug factories” may one day replace injections. Link

• Diagnosing disease with smartphone cameras. Link

• Potent new mechanism of action for treatment of inflammatory bowel disease revealed. Link

Perspective and Opinions 📢

• Asia on the move: Five trends shaping the Asian biopharma market. Link

• Why the pharmaceutical industry is giving up the search for an Alzheimer’s cure. Link

Interesting 🤔

• Americans distrusting Big Pharma seek traditional Chinese cures. Link

• What barbershops can teach about delivering healthcare. Link

Startups 💰

• Chinese investors lead Grail's $300M series C. Link

• Accent Therapeutics launches with $40 million Series A round. Link

• GC Pharma to establish Curevo - a Seattle-based new company dedicated to the development of new vaccines. Link

Our Digital Times 😃